Foundry Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,785
Closed -$260K 408
2017
Q3
$260K Hold
1,785
0.01% 374
2017
Q2
$232K Sell
1,785
-3,850
-68% -$472K 0.01% 399
2017
Q1
$701K Sell
5,635
-2,915
-34% -$349K 0.03% 358
2016
Q4
$990K Sell
8,550
-19,834
-70% -$2.21M 0.04% 346
2016
Q3
$2.97M Sell
28,384
-6,356
-18% -$688K 0.16% 209
2016
Q2
$3.43M Buy
34,740
+505
+1% +$52.2K 0.19% 168
2016
Q1
$3.43M Sell
34,235
-15,238
-31% -$1.57M 0.34% 81
2015
Q4
$5.92M Sell
49,473
-9,587
-16% -$1.11M 0.49% 72
2015
Q3
$6.39M Sell
59,060
-22,580
-28% -$2.8M 0.56% 58
2015
Q2
$9.45M Sell
81,640
-17,055
-17% -$1.95M 0.76% 37
2015
Q1
$11.4M Buy
98,695
+1,052
+1% +$126K 0.95% 28
2014
Q4
$10.9M Sell
97,643
-16,388
-14% -$1.73M 0.9% 39
2014
Q3
$10.8M Buy
+114,031
New +$10.3M 1% 26
2014
Q2
Sell
-9,290
Closed -$648K 304
2014
Q1
$648K Sell
9,290
-108,340
-92% -$8.58M 0.06% 214
2013
Q4
$9.94M Buy
+117,630
New +$9.31M 0.89% 25

Other funds holding CELG

Foundry Partners's CELG Position: Q4 2017 in Review

Foundry Partners sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,785 shares — an estimated $260K sold.

Foundry Partners first reported a position in CELG in Q4 2013 and held it in 15 quarters. The position peaked at $11.4M in Q1 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Foundry Partners reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Foundry Partners sold 1,785 Celgene Corp shares in Q4 2017, an estimated $260K.
  • Foundry Partners first reported a position in Celgene Corp in Q4 2013 and held it in 15 quarters.
  • Foundry Partners's Celgene Corp position peaked at $11.4M in Q1 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Foundry Partners's 13F filing for Q4 2017, filed 25 Jan 2018.